Iolyx
10 employees on LinkedIn · 2 known investors
Find your way into Iolyx
1,365 people in our graph share verified history with the Iolyx team — schools, employers, funds. One of them is your warm intro.
Wesley Chanunlockedknows Shannon Dahl · together at Massachusetts Institute of Technology (overlapped)
×4knows the team · via Massachusetts Institute of Technology
×3knows the team · via Stanford University
×2knows the team · via University of California, Berkeley
knows the team · via Santa Clara University School of Law
knows the team · via Roche
Iolyx is a pharmaceutical company focused on developing treatments for ocular conditions. The company assembles a team of experienced scientists, clinicians, and regulatory experts in drug development and ophthalmology.
Founders & leadership
EJ
Elizabeth JeffordsinCEO & PresidentShe previously held senior leadership roles at Roche and Genentech, including heading the Global Established Products Business Unit and overseeing the US ophthalmology business, with experience across commercial operations, product development, and regulatory affairs.
EN
Erin NewmaninChief Development Officer
SD
Shannon DahlinChief Scientific OfficerWith extensive experience in biotech, she has worked across R&D strategy, clinical development, regulatory affairs, and commercialization phases from early-stage research through Phase 3 trials.
BB
Bryan BoyleinChief Legal & Administrative OfficerBryan Boyle serves as Chief Legal & Administrative Officer at Iolyx, which develops treatments for ocular conditions. He has prior experience in intellectual property prosecution and litigation within biotech and pharma, along with transaction management and contract negotiation, and previously held the position of Vice President Legal at Alkahest, Inc.
Investors · 2
In the news
Frequently asked questions
- What does Iolyx do?
- Iolyx is a pharmaceutical company focused on developing treatments for ocular conditions. The company assembles a team of experienced scientists, clinicians, and regulatory experts in drug development and ophthalmology.
- Who are Iolyx's investors?
- Iolyx's investors include Frazier Life Sciences, Frazier Healthcare Partners.